Navigation Links
The PLSG Invests $115,000 in Innovention Technologies, LLC
Date:10/24/2007

PITTSBURGH, Oct. 24 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested $115,000 in Innovention Technologies, LLC, a developmental-stage medical device company, whose goal is to develop and commercialize a highly-maneuverable surgical probe that will alleviate the existing limitations of endoscopic devices used in minimally invasive surgery (MIS).

Innovention Technologies is a spin-out from Carnegie Mellon University and it is led by an interdisciplinary team of experts in robotics, robotic surgery and minimally-invasive cardiac surgery (MICS).

Innovention Technologies is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Innoventions' first product is a highly-articulated robotic probe (HARP) with feeder (the "HARP Product"). The HARP Product is highly maneuverable and once entered through a natural orifice or small incision, is designed to steer around organs to reach anatomical targets not normally accessible by conventional endoscopic tools. The HARP mechanical features include its ability to alternate between being rigid and flexible, and "remember" its previous configurations. This allows the HARP to reach very small cavities within the body and remain in a desired shape and orientation while the doctor performs surgery without having to hold the device anymore.

"The PLSG is excited to support Innoventions' continued commercialization efforts. Innoventions' core technology promises to combine advanced, yet simple methodologies in robotic surgery to more effectively deliver intended surgical benefits for increased patient care," said John W. Manzetti, PLSG's President and CEO. Mr. Manzetti continued, "The experienced management team has combined MIS and an emerging robotics technology to strategically and competitively position Innoventions in a large medical device market."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com

About Innovention Technologies, LLC

Innovention Technologies LLC is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The Company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Within the medical field, the Company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy and arthroscopy. http://www.innoventllc.com


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Milwaukee angel network invests in St. Louis company
2. Froedtert invests $1.5M in local medical imaging startup
3. GE Healthcare invests $37.5 million in Chinese bio-sciences manufacturing facility
4. Wisconsin Insurance Company Invests in DotCom Company
5. Madison business receives $115,000 of new state biofuels funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... SANTA MONICA, Calif. , March 22, 2017 ... Council (MassMEDIC) are proud to announce their extended partnership ... Week will be headlined by the 21 st ... UBM,s BIOMEDevice Boston, taking place May 3-4, 2017. ... with Advanced Medical Technology Association (ADVAMED) President and ...
(Date:3/22/2017)... 2017 MarketNewsUpdates.com News Commentary  ... The traditional ways ... pressured as of late due to the rise of the ... a dramatic impact on patient,s quality of life as Biotech ... identifying new forms of opioid formulations that prevent abuse. Biotech ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the information you ... activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ...
(Date:3/2/2017)... March 2, 2017 Who risk to be ... Download the full report: https://www.reportbuyer.com/product/4313699/ WILL ... SENSOR FIELD? Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
Breaking Biology News(10 mins):